Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrathecal neostigmine added to hyperbaric prilocaine for cesarean spinal anesthesia
PACTR202412678145639Phase 2Completed
- Sponsor
- Ain Shams University Faculty of Medicine
- Start
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of neostigmine and prilocaine in post-dural puncture headache (PDPH) and pain (2 arms), sponsored by Ain Shams University Faculty of Medicine. Primary endpoint: Incidence and severity of post-dural puncture headache. Started Jun 2023; status: completed.
02
Drugs
neostigmineprilocaine
03
Conditions
post-dural puncture headache (PDPH)pain
Beyond the preview
Go deeper on PACTR202412678145639.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202412678145639.